MATERNUS-Kliniken Stock

€1.39

0.72% yesterday

Xetra, Jul 07, 05:36 pm CET

ISIN

DE0006044001

Symbol

MAK

Index

CDAX

Sector

Health

Industry

Health service provider

Overview Dividends Analysts Charts News Strategies

MATERNUS-Kliniken Stock price

€1.39

-1.13 44.84% 5Y

Xetra, Closing price Mon, Jul 07 2025

+0.01 0.72%

ISIN

DE0006044001

Symbol

MAK

Index

CDAX

Sector

Health

Industry

Health service provider

Key metrics

Basic

Market capitalization

€28.9m

Enterprise Value

€205.9m

Net debt

€176.9m

Cash

€9.6m

Shares outstanding

21.0m

Valuation (TTM | estimate)

P/E

negative | -

P/S

0.2 | -

EV/Sales

1.3 | -

EV/FCF

15.7

P/B

negative

Financial Health

Equity Ratio

-34.8%

Return on Equity

26.5%

ROCE

-4.2%

ROIC

-2.9%

Debt/Equity

-3.4

Financials (TTM | estimate)

Revenue

€159.4m | -

EBITDA

€11.5m | -

EBIT

€-3.1m | -

Net Income

€-16.1m | -

Free Cash Flow

€13.1m

Growth (TTM | estimate)

Revenue

1.3% | -

EBITDA

1,645.5% | -

EBIT

79.1% | -

Net Income

30.9% | -

Free Cash Flow

763.6%

EPS

€-0.8

FCF per Share

€0.6

Short interest

Employees

Rev per Employee

€70.0k

As a Free StocksGuide user, you can view scores for all 6,988 stocks worldwide.

Get Started for Free Today

MATERNUS-Kliniken Stock Analysis

Unlock Scores for Free

??

7 Analysts have issued a MATERNUS-Kliniken forecast:

3x Hold

43%

4x Sell

57%

More details on Analyst Estimates Including Price Targets

7 Analysts have issued a MATERNUS-Kliniken forecast:

Hold

43%

Sell

57%

Analyst Estimates with Stock Price Targets

Financial data from MATERNUS-Kliniken

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Jun '24		+/- %
Revenue	159 159	1% 1% 100%
- Direct Costs	22 22	17% 17% 14%
Gross Profit	138 138	5% 5% 86%
- Selling and Administrative Expenses	113 113	4% 4% 71%
- Research and Development Expense	- -	- -
EBITDA	12 12	1,645% 1,645% 7%
- Depreciation and Amortization	15 15	6% 6% 9%
EBIT (Operating Income) EBIT	-3.13 -3.13	79% 79% -2%
Net Profit	-16 -16	31% 31% -10%

In millions EUR.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

MATERNUS-Kliniken Stock News

AD HOC NEWS

●

3 months ago

Maternus-Kliniken AG: Verspätung der Veröffentlichung des Jahres- und Konzernabschlusses für das Jahr 2024, Darlehensverlängerung

Maternus-Kliniken AG / DE0006044001

Company Profile

Maternus-Kliniken AG engages in the operation of senior housing facilities, nursing homes, and rehabilitation centers. It operates through the following segments: Rehabilitation, Senior Retirement Homes and Nursing Care Facilities, and Maternus AG. The Rehabilitation segment comprises follow-up treatment and rehabilitation measures in the indication areas orthopedics, behavioral orthopedics, cardiology, internal medicine, metabolic disorders, and neurology. The Senior Retirement Homes and Nursing Care Facilities segment specializes in full-station services care, short-term care, and assisted living. The Maternus AG segment provides primarily intersegmentary services. The company was founded in 1877 and is headquartered in Berlin, Germany.

Head office	Germany
CEO	Mario Ruano-Wohlers
Employees	1,452
Founded	1877
Website	www.maternus.de

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now